|
⚲
|
| Keyboard |
| Bures Thomas
✚
|
|
|---|---|
| CIK # | 0001787029 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001787029] | |
| 4 | [0001787029] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bruker Corp | |
| Bures Thomas | |
| Palvella Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bruker Corp BRKR
Common Stock
|
2026-02-15 | Tax withheld | 274 | $36.51 | 10,004 |
|
Bruker Corp BRKR
Common Stock
|
2025-03-10 | Buy | 500 | $47.40 | 23,700 |
|
Bruker Corp BRKR
Common Stock
|
2025-02-15 | Grant | 2,972 | $0.00 | |
|
Palvella Therapeutics Inc PIRS
Stock Option (right to buy) · derivative
|
2023-02-24 | Grant | 249,080 | $0.00 | |
|
Palvella Therapeutics Inc PIRS
Stock Options (Right to buy) · derivative
|
2022-02-22 | Grant | 215,819 | $0.00 | |
|
Palvella Therapeutics Inc PIRS
Stock Options (Right to buy) · derivative
|
2021-03-04 | Grant | 150,000 | $0.00 | |
|
Palvella Therapeutics Inc PIRS
Stock Option (Right to Buy) · derivative
|
2020-02-27 | Grant | 80,000 | $0.00 |